Colloidal Silver
Suspended silver particles
No medical benefit — and it can turn your skin permanently blue.
Evidence tier
No Evidence
Research weight
Not supported
Citations
18 verified / 18
Classification
Debunked
⊘
What the evidence says. No credible human evidence supports the marketed claims — widely considered ineffective.
⚠
Health warning. Colloidal silver has no proven benefit for any condition taken internally, and it can cause argyria — a permanent, irreversible blue-grey discoloration of the skin. Regulators consider it neither safe nor effective.
What is Colloidal Silver?
Colloidal Silver (Suspended silver particles) is a debunked supplement marketed for 'natural antibiotic' & immune cure-all. NutriDex grades the human evidence as No Evidence. Colloidal silver is suspended silver particles promoted as a 'natural antibiotic' and cure-all. Health authorities are clear: there is no scientific evidence it is effective for any internal condition, and it is not safe to take by mouth. Its most notorious harm is argyria — silver deposits that turn the skin a permanent blue-grey. The FDA has acted against products claiming colloidal silver treats disease.
Marketed Claims (unproven)
✕(Claimed) 'natural antibiotic' & immune cure-all
Dosing & Compounds
Use & Legality
No safe or effective oral dose — health authorities advise against ingestion.
Active Compounds
Safety & Cautions
⚠ Causes argyria — permanent, irreversible blue-grey skin/eyes. May impair absorption of antibiotics and thyroid medication. No proven benefit to offset these risks. Avoid internal use. Educational only — always check with your doctor or pharmacist before combining Colloidal Silver with any medicine.
Evidence & Risk Findings ★ 18 studies
meta-analysis
Medical Principles and Practice 2024
✓ Full text
Meta-analysis of 18 RCTs (1,825 patients) found topical silver dressings improved healing of diabetic foot ulcers (OR 2.14, 95% CI 1.52-3.00) but showed no significant benefit for venous leg ulcers (OR 1.32, 95% CI 0.97-1.78), indicating any topical benefit is ulcer-type specific.
Agency / regulator
NCCIH 2023
✓ Source
US NCCIH/FDA state silver has no known body function, is not an essential mineral, is unsafe (causes permanent argyria and may harm kidney/liver/nervous system and impair drug absorption), and nasal-spray studies for sinus infection showed no meaningful benefit; no evidence for COVID-19.
regulator action
FTC/FDA COVID-19 warning letters 2020
✓ Source
Regulators issued warning letters to multiple companies (including a colloidal silver marketer) for unsupported claims that silver products treat or prevent COVID-19, citing lack of competent scientific evidence.
Agency / regulator
NIH / NCCIH
✓ Source
States colloidal silver is not safe or effective for any claimed use.
Agency / regulator
FDA Ruling 1999
✓ PubMed
Over-the-counter colloidal silver products are not recognized as safe and effective.
Guideline
FDA Final Rule, 21 CFR 310.548 (1999)
✓ Source
Landmark regulatory ruling: ALL over-the-counter drug products containing colloidal silver or silver salts are NOT generally recognized as safe and effective for any disease or condition; manufacturers failed to provide required absorption, distribution, accumulation and efficacy data. Established no benefit and codified enforcement against internal/OTC colloidal silver claims.
toxicology assessment
Toxics 2025
✓ Full text
Physicochemical analysis of commercial oral colloidal silver supplements found estimated daily silver intake at maximum recommended doses can exceed EPA safety thresholds, indicating risk of chronic accumulation and systemic toxicity.
RCT
Smock/Munger et al. (2013)
✓ PubMed
Placebo-controlled, single-blind, crossover trial in 18 healthy volunteers given daily oral commercial silver nanoparticles for 2 weeks: no detectable enhancement of ex vivo platelet aggregation at peak serum silver <10 ug/L. One of the very few human interventional studies of ingested colloidal/nanosilver — assessed safety endpoints, demonstrated no clinical benefit.
narrative review
Frontiers Cell Infect Microbiol 2025
✓ Full text
Review concludes silver nanoparticles show in vitro antimicrobial potential against multidrug-resistant bacteria but face major barriers to clinical translation, including mammalian cytotoxicity (especially <10 nm), emerging bacterial resistance, and lack of selectivity.
Review
Bute et al. (2025)
✓ PubMed
Physicochemical characterization of commercial oral colloidal silver supplements (up to 1000 mg/L, poorly labelled): estimated daily intakes exceed the US EPA oral reference dose of 0.005 mg/kg/day, indicating a real toxicological risk and the need for stricter regulation; no therapeutic benefit demonstrated.
Observational
Stjernbrandt 2023
✓ Full text
Case report: a woman who ingested 150 µg/day colloidal silver for 2-3 weeks developed severe macrocytic anemia (RBC 48 g/L), thrombocytopenia (platelets 52 x10^9/L), abnormal liver function and early heart failure, with whole-blood silver of 20.0 µg/L falling to 3.3 µg/L over ~3 months.
Observational
Collins 2025 (MJA)
✓ Full text
Case report: a 63-year-old man who used homemade silver solution for a flu-like illness after reading online antiviral claims developed permanent blue-grey argyria on sun-exposed skin, illustrating harm from health misinformation about silver.
Safety / toxicology
Argyria case reports
✓ Full text
Documented permanent blue-grey skin discoloration from ingestion.
Review
Hadrup & Lam (2013)
✓ PubMed
Oral toxicity review: orally administered silver is absorbed ~18% in humans and distributes to all organs (highest in intestine/stomach), inducing argyria; particle effects are mediated by released silver ions. Margin-of-safety calculation gives only a factor of ~5 before a level of concern for the general population — i.e., a narrow safety window with no efficacy benefit.
systematic-review
Cochrane Review (CD006478)
✓ Full text
Cochrane systematic review (26 RCTs, ~2,066 participants) found insufficient evidence that silver-containing dressings or topical agents promote wound healing or prevent infection, with low-quality evidence suggesting silver sulfadiazine may actually delay healing of partial-thickness burns.
Review
Kim et al. (2009)
✓ PubMed
Documented case of generalized argyria after ingesting ~1 L/day of colloidal silver solution for ~16 months: diffuse permanent blue-gray skin/mucosal discoloration with serum silver 381 ng/mL (reference <15 ng/mL), confirmed by EDX showing silver-sulfur deposits. Illustrates the principal documented human harm of oral colloidal silver.
case report
Argyria of nails case study 2022
✓ PubMed
Case report documenting bilateral blue-grey pigmentary changes confined to the nail beds following chronic oral colloidal silver ingestion, illustrating an early sign of argyria.
case-report
Hospital Pharmacy 2023
✓ PubMed
Case report of a 70-year-old man who developed new-onset seizures as the presenting manifestation of silver toxicity after self-medicating with oral colloidal silver, illustrating rare but serious neurotoxicity beyond argyria.